Habte Yimer, MD from Texas Oncology discusses Daratumumab studies have shown significant benefits and effective in combination with CyBorD at the 2017 American Society of Hematology.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content